BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 19383857)

  • 1. Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia.
    May C; Williams O; Milner AD; Peacock J; Rafferty GF; Hannam S; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F205-9. PubMed ID: 19383857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung function abnormalities in infants developing bronchopulmonary dysplasia.
    May C; Kennedy C; Milner AD; Rafferty GF; Peacock JL; Greenough A
    Arch Dis Child; 2011 Nov; 96(11):1014-9. PubMed ID: 21908881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung function and exhaled nitric oxide levels in infants developing chronic lung disease.
    Williams O; Dimitriou G; Hannam S; Rafferty GF; Greenough A
    Pediatr Pulmonol; 2007 Feb; 42(2):107-13. PubMed ID: 17186509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCO2 and room air saturation values in premature infants at risk for bronchopulmonary dysplasia.
    Kaempf JW; Campbell B; Brown A; Bowers K; Gallegos R; Goldsmith JP
    J Perinatol; 2008 Jan; 28(1):48-54. PubMed ID: 18033306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of bronchopulmonary dysplasia.
    May C; Patel S; Kennedy C; Pollina E; Rafferty GF; Peacock JL; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2011 Nov; 96(6):F410-6. PubMed ID: 21362700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation.
    Baraldi E; Bonetto G; Zacchello F; Filippone M
    Am J Respir Crit Care Med; 2005 Jan; 171(1):68-72. PubMed ID: 15477497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the new definition of bronchopulmonary dysplasia more useful?
    Sahni R; Ammari A; Suri MS; Milisavljevic V; Ohira-Kist K; Wung JT; Polin RA
    J Perinatol; 2005 Jan; 25(1):41-6. PubMed ID: 15538399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleeping position, oxygenation and lung function in prematurely born infants studied post term.
    Saiki T; Rao H; Landolfo F; Smith AP; Hannam S; Rafferty GF; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2009 Mar; 94(2):F133-7. PubMed ID: 19240293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health status at the age of 5-7 years of preterm infants with and without bronchopulmonary dysplasia].
    Kwinta P; Tomasik T; Klimek M; Cichocka-Jarosz E; Lis G; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):21-6. PubMed ID: 19485251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a physiologic definition on bronchopulmonary dysplasia rates.
    Walsh MC; Yao Q; Gettner P; Hale E; Collins M; Hensman A; Everette R; Peters N; Miller N; Muran G; Auten K; Newman N; Rowan G; Grisby C; Arnell K; Miller L; Ball B; McDavid G;
    Pediatrics; 2004 Nov; 114(5):1305-11. PubMed ID: 15520112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone.
    Aghai ZH; Faqiri S; Saslow JG; Nakhla T; Farhath S; Kumar A; Eydelman R; Strande L; Stahl G; Leone P; Bhandari V
    J Perinatol; 2008 Feb; 28(2):149-55. PubMed ID: 18033304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bronchopulmonary dysplasia in ex-prematures approaching adulthood].
    Vrijlandt EJ; Gerritsen J; Duiverman EJ
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2445-51. PubMed ID: 18064864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide.
    Truog WE; Ballard PL; Norberg M; Golombek S; Savani RC; Merrill JD; Parton LA; Cnaan A; Luan X; Ballard RA;
    Pediatrics; 2007 Apr; 119(4):670-8. PubMed ID: 17403837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops.
    Watterberg KL; Demers LM; Scott SM; Murphy S
    Pediatrics; 1996 Feb; 97(2):210-5. PubMed ID: 8584379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled nitric oxide differentiates airway diseases in the first two years of life.
    Gabriele C; Nieuwhof EM; Van Der Wiel EC; Hofhuis W; Moll HA; Merkus PJ; De Jongste JC
    Pediatr Res; 2006 Oct; 60(4):461-5. PubMed ID: 16940253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intubation and mechanical ventilation on exhaled nitric oxide in preterm infants with and without bronchopulmonary dysplasia measured at a median postmenstrual age of 49 weeks.
    Schmalisch G; Wilitzki S; Fischer HS; Bührer C
    BMC Res Notes; 2014 Jun; 7():389. PubMed ID: 24957096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO; Anstead MI; Shook LA
    Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled air temperature in children with bronchopulmonary dysplasia.
    Carraro S; Piacentini G; Lusiani M; Uyan ZS; Filippone M; Schiavon M; Boner AL; Baraldi E
    Pediatr Pulmonol; 2010 Dec; 45(12):1240-5. PubMed ID: 20717936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.